VERTIS CV Trial: The SGLT-2 inhibitors are the next generation drugs for type 2 diabetes as well as patients with heart failure. We have seen…
The SGLT-2 inhibitor class drugs were initially developed as diabetic medications. The FDA required all diabetic drugs to showcase CV safety before their approval. This…